{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:16:16Z","timestamp":1783606576535,"version":"3.55.0"},"reference-count":56,"publisher":"Bioscientifica","issue":"4","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>More than 15 case\u2013control studies and at least four large cohort studies demonstrated a decrease in the risk of endometrial cancer of about 50% for ever use of combined oral contraceptives (COCs). In most of these studies, this protective effect persisted for more than 10\u201315\u201320 years after cessation of the COC. An increasing protective effect with longer duration of COC use has been found in most studies. The beneficial effect was independent of the composition of COC, i.e. dosage and type of progestogen, combined with ethinyl estradiol 30\u201350\u200a\u03bcg\/day. COCs with higher progestogen potency seem to be somewhat more effective. Nonhormonal uterine devices have also been found to be strongly protective; however, data on oral or injectable progestogen-only preparations (POPs) including the levonorgestrel-releasing intrauterine system (LNG-IUS) are still rare, but also suggest similar protective action. COCs, POPs, as well as LNG-IUS can effectively reduce endometrial hyperplasia but should only be used in exceptional cases in patients with or after endometrial cancer. In contrast to nonhormonal IUS, systemic side effects cannot be excluded with LNG-IUS, but they are certainly rare, as the main effect has decreased the endometrial estrogen response because of the high endometrial tissue levels of LNG.<\/jats:p>","DOI":"10.1677\/erc-10-0076","type":"journal-article","created":{"date-parts":[[2010,9,24]],"date-time":"2010-09-24T20:53:56Z","timestamp":1285361636000},"page":"R263-R271","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":82,"title":["Hormonal contraception and risk of endometrial cancer: a systematic review"],"prefix":"10.1530","volume":"17","author":[{"given":"Alfred O","family":"Mueck","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Menopause","department":["Centre for Women's Health BW, University Women's Hospital, Calwer Strasse 7, D-72076 Tuebingen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Seeger","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Menopause","department":["Centre for Women's Health BW, University Women's Hospital, Calwer Strasse 7, D-72076 Tuebingen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rabe","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Menopause","department":["Centre for Women's Health BW, University Women's Hospital, Calwer Strasse 7, D-72076 Tuebingen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2026070909272990000_bib1","unstructured":"Aikat\n              M\n            \n            \n              Chadda\n              U\n            \n          \n          1980\n          Long-term effects of copper intrauterine devices on cervical epithelium and endometrium. Indian Journal of Medical Research71879\u2013883."},{"key":"2026070909272990000_bib2","doi-asserted-by":"crossref","unstructured":"Beining\n              RM\n            \n            \n              Dennis\n              LK\n            \n            \n              Smith\n              EM\n            \n            \n              Dokras\n              A\n            \n          \n          2008\n          Meta-analysis of intrauterine device use and risk of endometrial cancer. Annals of Epidemiology18492\u2013499doi:10.1016\/j.annepidem.2007.11.011.","DOI":"10.1016\/j.annepidem.2007.11.011"},{"key":"2026070909272990000_bib3","doi-asserted-by":"crossref","unstructured":"Beral\n              V\n            \n            \n              Hannaford\n              P\n            \n            \n              Kay\n              C\n            \n          \n          1988\n          Oral contraceptive use and malignancies of the genital tract: results from the Royal College of General Practitioners\u2019 Oral Contraception Study. Lancet3321331\u20131335doi:10.1016\/S0140-6736(88)90869-0.","DOI":"10.1016\/S0140-6736(88)90869-0"},{"key":"2026070909272990000_bib4","unstructured":"Brinton\n              LA\n            \n            \n              Hoover\n              RN\n            \n          \n          1993\n          Estrogen replacement therapy and endometrial cancer risk: unresolved issues. Obstetrics and Gynecology81265\u2013271."},{"key":"2026070909272990000_bib5","doi-asserted-by":"crossref","unstructured":"CASH (Cancer and Steroid Hormone)\n          Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. Combination oral contraceptive use and the risk of endometrial cancer\n          Journal of the American Medical Association\n          257\n          1987\n          796\u2013800doi:10.1001\/jama.257.6.796.","DOI":"10.1001\/jama.1987.03390060086029"},{"key":"2026070909272990000_bib6","doi-asserted-by":"crossref","unstructured":"Castellsague\n              X\n            \n            \n              Thompson\n              WD\n            \n            \n              Dubrow\n              R\n            \n          \n          1993\n          Intra-uterine contraception and the risk of endometrial cancer. International Journal of Cancer54911\u2013916doi:10.1002\/ijc.2910540607.","DOI":"10.1002\/ijc.2910540607"},{"key":"2026070909272990000_bib7","doi-asserted-by":"crossref","unstructured":"Chan\n              SSC\n            \n            \n              Tam\n              WH\n            \n            \n              Yeo\n              W\n            \n            \n              Yu\n              MMY\n            \n            \n              Ng\n              DPS\n            \n            \n              Wong\n              AWY\n            \n            \n              Kwan\n              WH\n            \n            \n              Yuen\n              PM\n            \n          \n          2007\n          A randomised controlled trial of prophylactic levonorgestrel intra-uterine system in tamoxifen-treated women. British Journal of Obstetrics and Gynaecology1141510\u20131515doi:10.1111\/j.1471-0528.2007.01545.x.","DOI":"10.1111\/j.1471-0528.2007.01545.x"},{"key":"2026070909272990000_bib8","doi-asserted-by":"crossref","unstructured":"Dhar\n              KK\n            \n            \n              NeedhiRajan\n              T\n            \n            \n              Koslowski\n              M\n            \n            \n              Woolas\n              RP\n            \n          \n          2005\n          Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature.. Gynecologic Oncology97924\u2013927doi:10.1016\/j.ygyno.2004.10.031.","DOI":"10.1016\/j.ygyno.2004.10.031"},{"key":"2026070909272990000_bib9","doi-asserted-by":"crossref","unstructured":"Gardner\n              FJE\n            \n            \n              Konje\n              JC\n            \n            \n              Abrams\n              KR\n            \n            \n              Browns\n              LJR\n            \n            \n              Khanna\n              S\n            \n            \n              Al-Azzawi\n              F\n            \n            \n              Bell\n              SC\n            \n            \n              Taylor\n              DJ\n            \n          \n          2000\n          Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial. Lancet3561711\u20131717doi:10.1016\/S0140-6736(00)03204-9.","DOI":"10.1016\/S0140-6736(00)03204-9"},{"key":"2026070909272990000_bib10","doi-asserted-by":"crossref","unstructured":"Giannopoulos\n              T\n            \n            \n              Butler-Mauel\n              S\n            \n            \n              Tailor\n              A\n            \n          \n          2004\n          Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma. Gynecologic Oncology95762\u2013764doi:10.1016\/j.ygyno.2004.09.010.","DOI":"10.1016\/j.ygyno.2004.09.010"},{"key":"2026070909272990000_bib11","doi-asserted-by":"crossref","unstructured":"Grimes\n              DA\n            \n            \n              Economy\n              KE\n            \n          \n          1995\n          Primary prevention of gynecologic cancers. American Journal of Obstetrics and Gynecology172227\u2013235doi:10.1016\/0002-9378(95)90125-6.","DOI":"10.1016\/0002-9378(95)90125-6"},{"key":"2026070909272990000_bib12","doi-asserted-by":"crossref","unstructured":"Haimovich\n              S\n            \n            \n              Checa\n              MA\n            \n            \n              Mancebo\n              G\n            \n            \n              Fuste\n              P\n            \n            \n              Carreras\n              R\n            \n          \n          2008\n          Treatment of endometrial hyperplasia without atypia in peri- and postmenopausal women with a levonorgestrel intrauterine device. Menopause151002\u20131007doi:10.1097\/gme.0b013e3181659837.","DOI":"10.1097\/gme.0b013e3181659837"},{"key":"2026070909272990000_bib13","doi-asserted-by":"crossref","unstructured":"Hannaford\n              PC\n            \n            \n              Selvaraj\n              S\n            \n            \n              Elliott\n              AM\n            \n            \n              Angus\n              V\n            \n            \n              Iversen\n              L\n            \n            \n              Lee\n              AJ\n            \n          \n          2007\n          Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's Oral Contraception Study. BMJ335651doi:10.1136\/bmj.39289.649410.55.","DOI":"10.1136\/bmj.39289.649410.55"},{"key":"2026070909272990000_bib14","doi-asserted-by":"crossref","unstructured":"Heinemann\n              LAJ\n            \n            \n              Lewis\n              MA\n            \n            \n              K\u00fchl-Habich\n              D\n            \n            \n              Braendle\n              W\n            \n            \n              Moehner\n              S\n            \n            \n              Raff\n              T\n            \n          \n          2003\n          Use of oral contraceptives and risk of cancer of the uterine corpus or ovary. Two case\u2013control studies. Geburtshilfe und Frauenheilkunde631018\u20131026doi:10.1055\/s-2003-42732.","DOI":"10.1055\/s-2003-42732"},{"key":"2026070909272990000_bib15","doi-asserted-by":"crossref","unstructured":"Henderson\n              BE\n            \n            \n              Casagrande\n              JT\n            \n            \n              Pike\n              MC\n            \n            \n              Mack\n              T\n            \n            \n              Rosario\n              I\n            \n            \n              Duke\n              A\n            \n          \n          1983\n          The epidemiology of endometrial cancer in young women. British Journal of Cancer47749\u2013756.","DOI":"10.1038\/bjc.1983.127"},{"key":"2026070909272990000_bib16","doi-asserted-by":"crossref","unstructured":"Horwitz\n              RI\n            \n            \n              Feinstein\n              AR\n            \n          \n          1979\n          Case\u2013control study of oral contraceptive pills and endometrial cancer. Annals of Internal Medicine91226\u2013227.","DOI":"10.7326\/0003-4819-91-2-226"},{"key":"2026070909272990000_bib17","doi-asserted-by":"crossref","unstructured":"Hubacher\n              D\n            \n            \n              Grimes\n              DA\n            \n          \n          2002\n          Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstetrical and Gynecological Survey57120\u2013128doi:10.1097\/00006254-200202000-00024.","DOI":"10.1097\/00006254-200202000-00024"},{"key":"2026070909272990000_bib18","doi-asserted-by":"crossref","unstructured":"Hulka\n              BS\n            \n            \n              Chambless\n              LE\n            \n            \n              Kaufman\n              DG\n            \n            \n              Fowler\n              WC\n              Jr\n            \n            \n              Greenberg\n              BG\n            \n          \n          1982\n          Protection against endometrial carcinoma by combination-product oral contraceptives. Journal of the American Medical Association247475\u2013477doi:10.1001\/jama.247.4.475.","DOI":"10.1001\/jama.1982.03320290021022"},{"key":"2026070909272990000_bib19","unstructured":"Jick\n              SS\n            \n            \n              Waler\n              AM\n            \n            \n              Jick\n              H\n            \n          \n          1993\n          Oral contraceptives and endometrial cancer. Obstetrics and Gynecology82931\u2013935."},{"key":"2026070909272990000_bib20","doi-asserted-by":"crossref","unstructured":"Johannisson\n              E\n            \n          \n          1987\n          Mechanism of action of intrauterine devices: biochemical changes. Contraception3611\u201322doi:10.1016\/0010-7824(87)90058-8.","DOI":"10.1016\/0010-7824(87)90058-8"},{"key":"2026070909272990000_bib21","doi-asserted-by":"crossref","unstructured":"Kaufman\n              DW\n            \n            \n              Shapiro\n              S\n            \n            \n              Slone\n              D\n            \n            \n              Rosenberg\n              L\n            \n            \n              Miettinen\n              OS\n            \n            \n              Stolley\n              PD\n            \n            \n              Knapp\n              RC\n            \n            \n              Leavitt\n              T\n              Jr\n            \n            \n              Watring\n              WG\n            \n            \n              Roseshein\n              NB\n            \n            \n          \n          1980\n          Decreased risk of endometrial cancer among oral contraceptive users. New England Journal of Medicine3031045\u20131047doi:10.1056\/NEJM198010303031807.","DOI":"10.1056\/NEJM198010303031807"},{"key":"2026070909272990000_bib22","unstructured":"Kelsey\n              JL\n            \n            \n              LiVolsi\n              VA\n            \n            \n              Holford\n              TR\n            \n            \n              Fischer\n              DB\n            \n            \n              Mostow\n              ED\n            \n            \n              Schwartz\n              PE\n            \n          \n          1982\n          A case\u2013control study of cancer of the endometrium. American Journal of Epidemiology116333\u2013342."},{"key":"2026070909272990000_bib23","doi-asserted-by":"crossref","unstructured":"Kesim\n              MD\n            \n            \n              Aydin\n              Y\n            \n            \n              Atis\n              A\n            \n            \n              Mandiraci\n              G\n            \n          \n          2008\n          Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast-cancer patients taking tamoxifen. Climacteric11252\u2013257doi:10.1080\/13697130802163168.","DOI":"10.1080\/13697130802163168"},{"key":"2026070909272990000_bib24","doi-asserted-by":"crossref","unstructured":"Koumantaki\n              Y\n            \n            \n              Tzonou\n              A\n            \n            \n              Koumantakis\n              E\n            \n            \n              Kaklamani\n              E\n            \n            \n              Aravantinos\n              D\n            \n            \n              Trichopoulos\n              D\n            \n          \n          1989\n          A case\u2013control study of cancer of the endometrium in Athens. International Journal of Cancer43795\u2013799doi:10.1002\/ijc.2910430509.","DOI":"10.1002\/ijc.2910430509"},{"key":"2026070909272990000_bib25","doi-asserted-by":"crossref","unstructured":"Kresowik\n              J\n            \n            \n              Ryan\n              GL\n            \n            \n              Van Voorhis\n              BJ\n            \n          \n          2008\n          Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system. Obstetrics and Gynecology111547\u2013549doi:10.1097\/01.AOG.0000300716.84819.c6.","DOI":"10.1097\/01.AOG.0000300716.84819.c6"},{"key":"2026070909272990000_bib26","unstructured":"LaVecchia\n              C\n            \n            \n              Decarli\n              A\n            \n            \n              Parazzini\n              F\n            \n            \n              Gentile\n              A\n            \n            \n              Liberati\n              C\n            \n            \n              Franceschi\n              S\n            \n          \n          1986\n          Oral contraceptives and cancers of the breast and oft the female genital tract: interim results from a case\u2013control study. British Journal of Cancer54311\u2013317."},{"key":"2026070909272990000_bib27","doi-asserted-by":"crossref","unstructured":"Levi\n              F\n            \n            \n              La Vecchia\n              C\n            \n            \n              Gulie\n              C\n            \n            \n              Negri\n              E\n            \n            \n              Monnier\n              V\n            \n            \n              Franceschi\n              S\n            \n            \n              Delaloye\n              JF\n            \n            \n              De Grandi\n              P\n            \n          \n          1991\n          Oral contraceptives and the risk of endometrial cancer. Cancer Causes and Control299\u2013103doi:10.1007\/BF00053128.","DOI":"10.1007\/BF00053128"},{"key":"2026070909272990000_bib28","doi-asserted-by":"crossref","unstructured":"Maxwell\n              GL\n            \n            \n              Schildkraut\n              JM\n            \n            \n              Calingaert\n              B\n            \n            \n              Risinger\n              JI\n            \n            \n              Dainty\n              L\n            \n            \n              Marchbanks\n              PA\n            \n            \n              Berchuck\n              A\n            \n            \n              Barrett\n              JC\n            \n            \n              Rodriguez\n              GC\n            \n          \n          2006\n          Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk (CASH-study). Gynecologic Oncology103535\u2013540doi:10.1016\/j.ygyno.2006.03.046.","DOI":"10.1016\/j.ygyno.2006.03.046"},{"key":"2026070909272990000_bib29","doi-asserted-by":"crossref","unstructured":"Nilsson\n              CH\n            \n            \n              Haukkamaa\n              M\n            \n            \n              Vierola\n              H\n            \n            \n              Luukainen\n              T\n            \n            \n              Arcangeli\n              P\n            \n          \n          1982\n          Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clinical Endocrinology17529\u2013536doi:10.1111\/j.1365-2265.1982.tb01625.x.","DOI":"10.1111\/j.1365-2265.1982.tb01625.x"},{"key":"2026070909272990000_bib30","doi-asserted-by":"crossref","unstructured":"Oerbo\n              A\n            \n            \n              Arnes\n              M\n            \n            \n              Hancke\n              C\n            \n            \n              Vereide\n              AB\n            \n            \n              Pettersen\n              I\n            \n            \n              Larsen\n              K\n            \n          \n          2008\n          Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing the effect of LNG-IUD and oral progestins versus observation only. Gynecologic Oncology11168\u201373doi:10.1016\/j.ygyno.2008.06.014.","DOI":"10.1016\/j.ygyno.2008.06.014"},{"key":"2026070909272990000_bib31","unstructured":"Parazzini\n              F\n            \n            \n              LaVecchia\n              C\n            \n            \n              Moroni\n              S\n            \n          \n          1994\n          Intrauterine device use and risk of endometrial cancer. British Journal of Cancer70672\u2013673."},{"key":"2026070909272990000_bib32","doi-asserted-by":"crossref","unstructured":"Pettersson\n              B\n            \n            \n              Adami\n              HO\n            \n            \n              Bergstrom\n              R\n            \n            \n              Johansson\n              EDB\n            \n          \n          1986\n          Menstruation span \u2013 a time-limited risk factor for endometrial carcinoma. Acta Obstetricia et Gynecologica Scandinavica65247\u2013255doi:10.3109\/00016348609155179.","DOI":"10.3109\/00016348609155179"},{"key":"2026070909272990000_bib33","doi-asserted-by":"crossref","unstructured":"Phillips\n              V\n            \n            \n              Graham\n              CT\n            \n            \n              Manek\n              S\n            \n            \n              McCluggage\n              WG\n            \n          \n          2003\n          The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology. Journal of Clinical Pathology56305\u2013307doi:10.1136\/jcp.56.4.305.","DOI":"10.1136\/jcp.56.4.305"},{"key":"2026070909272990000_bib34","doi-asserted-by":"crossref","unstructured":"Pike\n              MC\n            \n            \n              Spicer\n              D\n            \n          \n          2000\n          Hormonal contraception and chemoprevention of female cancers. Endocrine-Related Cancer773\u201383doi:10.1677\/erc.0.0070073.","DOI":"10.1677\/erc.0.0070073"},{"key":"2026070909272990000_bib35","doi-asserted-by":"crossref","unstructured":"Qi\n              X\n            \n            \n              Zhao\n              W\n            \n            \n              Duan\n              Y\n            \n            \n              Li\n              Y\n            \n          \n          2008\n          Successful pregnancy following insertion of a levonorgestrel-releasing intrauterine system in two patients with complex atypical endometrial hyperplasia. Gynecologic and Obstetric Investigation65266\u2013268doi:10.1159\/000113308.","DOI":"10.1159\/000113308"},{"key":"2026070909272990000_bib36","unstructured":"Ramcharan S, Pellegrin FA, Ray R & Hsu JP 1981 The Walnut Creek Contraceptive Drug Study: a prospective study of the side effects of oral contraceptives. In Volume III. An interim report: a comparison of disease occurance leading to hospitalization or death in users and nonusers of oral contraceptives. Bethesda, MD, USA: US Department of Health, Education, and Welfare."},{"key":"2026070909272990000_bib37","doi-asserted-by":"crossref","unstructured":"Raudaskoski\n              T\n            \n            \n              Knip\n              M\n            \n            \n              Laatikainen\n              T\n            \n          \n          1998\n          Plasma insulin-like growth factor 1 and its binding proteins 1 and 3 during coninuous non-oral and oral combined hormone replacement therapy. Menopause5217\u2013222doi:10.1097\/00042192-199805040-00006.","DOI":"10.1097\/00042192-199805040-00006"},{"key":"2026070909272990000_bib38","doi-asserted-by":"crossref","unstructured":"Riphagen\n              FE\n            \n          \n          2000\n          Intrauterine application of progestins in hormone replacement therapy: a review. Climacteric3199\u2013211doi:10.1080\/13697130008500114.","DOI":"10.1080\/13697130008500114"},{"key":"2026070909272990000_bib39","doi-asserted-by":"crossref","unstructured":"Schlesselman\n              JJ\n            \n          \n          1997\n          Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis. Human Reproduction121851\u20131863doi:10.1093\/humrep\/12.9.1851.","DOI":"10.1093\/humrep\/12.9.1851"},{"key":"2026070909272990000_bib40","doi-asserted-by":"crossref","unstructured":"Shu\n              XO\n            \n            \n              Brinton\n              LA\n            \n            \n              Zheng\n              W\n            \n            \n              Gao\n              YT\n            \n            \n              Fan\n              J\n            \n            \n              Fraumeni\n              JF\n            \n          \n          1991\n          A population-based case\u2013control study of endometrial cancer in Shanghai, China. International Journal of Cancer4938\u201343doi:10.1002\/ijc.2910490108.","DOI":"10.1002\/ijc.2910490108"},{"key":"2026070909272990000_bib41","doi-asserted-by":"crossref","unstructured":"Stanford\n              JL\n            \n            \n              Brinton\n              LA\n            \n            \n              Berman\n              ML\n            \n            \n              Mortel\n              R\n            \n            \n              Twiggs\n              LB\n            \n            \n              Barrett\n              RJ\n            \n            \n              Wilbanks\n              GD\n            \n            \n              Hoover\n              RN\n            \n          \n          1993\n          Oral contraceptives and endometrial cancer: do other risk factors modify the association?\n          International Journal of Cancer\n          54\n          243\u2013248doi:10.1002\/ijc.2910540214.","DOI":"10.1002\/ijc.2910540214"},{"key":"2026070909272990000_bib42","doi-asserted-by":"crossref","unstructured":"Sturgeon\n              SR\n            \n            \n              Brinton\n              LA\n            \n            \n              Berman\n              MI\n            \n            \n              Mortel\n              R\n            \n            \n              Twiggs\n              LB\n            \n            \n              Barrett\n              RJ\n            \n            \n              Wilbanks\n              GD\n            \n            \n              Lurain\n              JR\n            \n          \n          1997\n          Intrauterine device use and endometrial cancer risk. International Journal of Epidemiology26496\u2013500.","DOI":"10.1093\/ije\/26.3.496"},{"key":"2026070909272990000_bib43","doi-asserted-by":"crossref","unstructured":"Tao\n              MH\n            \n            \n              Xu\n              WH\n            \n            \n              Zheng\n              W\n            \n            \n              Zhang\n              Z-F\n            \n            \n              Gao\n              Y-T\n            \n            \n              Ruan\n              ZX\n            \n            \n              Cheng\n              JR\n            \n            \n              Gao\n              J\n            \n            \n              Xiang\n              YB\n            \n            \n              Shu\n              XO\n            \n          \n          2006\n          Oral contraceptive and IUD use and endometrial cancer: a population-based case\u2013control study in Shanghai, China. International Journal of Cancer1192142\u20132147doi:10.1002\/ijc.22081.","DOI":"10.1002\/ijc.22081"},{"key":"2026070909272990000_bib44","doi-asserted-by":"crossref","unstructured":"Trapido\n              EJ\n            \n          \n          1983\n          A prospective cohort study of oral contraceptives and cancer of the endometrium. International Journal of Epidemiology12297\u2013300doi:10.1093\/ije\/12.3.297.","DOI":"10.1093\/ije\/12.3.297"},{"key":"2026070909272990000_bib45","doi-asserted-by":"crossref","unstructured":"Varila\n              E\n            \n            \n              Wahlstrom\n              T\n            \n            \n              Rauramo\n              I\n            \n          \n          2001\n          A 5-year follow-up study on the use of levonorgestrel intrauterine system in women receiving hormone replacement therapy. Fertility and Sterility76969\u2013973doi:10.1016\/S0015-0282(01)02846-1.","DOI":"10.1016\/S0015-0282(01)02846-1"},{"key":"2026070909272990000_bib46","doi-asserted-by":"crossref","unstructured":"Varma\n              R\n            \n            \n              Soneja\n              H\n            \n            \n              Bhatia\n              K\n            \n            \n              Ganesan\n              R\n            \n            \n              Rollason\n              T\n            \n            \n              Clark\n              TJ\n            \n            \n              Gupta\n              JK\n            \n          \n          2008\n          The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia \u2013 a long-term follow-up study. European Journal of Obstetrics, Gynecology, and Reproductive Biology139169\u2013175doi:10.1016\/j.ejogrb.2008.02.022.","DOI":"10.1016\/j.ejogrb.2008.02.022"},{"key":"2026070909272990000_bib47","doi-asserted-by":"crossref","unstructured":"Vereide\n              AB\n            \n            \n              Arnes\n              M\n            \n            \n              Straume\n              B\n            \n            \n              Maltau\n              JM\n            \n            \n              Oerbo\n              A\n            \n          \n          2003\n          Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone. Gynecologic Oncology91526\u2013533doi:10.1016\/j.ygyno.2003.07.002.","DOI":"10.1016\/j.ygyno.2003.07.002"},{"key":"2026070909272990000_bib48","doi-asserted-by":"crossref","unstructured":"Vereide\n              AB\n            \n            \n              Kaino\n              T\n            \n            \n              Sager\n              G\n            \n            \n              Oerbo\n              A\n            \n          \n          2005\n          Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high-dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone. Gynecologic Oncology97740\u2013750doi:10.1016\/j.ygyno.2005.02.030.","DOI":"10.1016\/j.ygyno.2005.02.030"},{"key":"2026070909272990000_bib49","doi-asserted-by":"crossref","unstructured":"Vereide\n              AB\n            \n            \n              Kaino\n              T\n            \n            \n              Sager\n              G\n            \n            \n              Arnes\n              M\n            \n            \n              Oerbo\n              A\n            \n          \n          2006\n          Effect of levornorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors and estrogen receptors in human endometrial hyperplasia. Gynecologic Oncology101214\u2013223doi:10.1016\/j.ygyno.2005.10.030.","DOI":"10.1016\/j.ygyno.2005.10.030"},{"key":"2026070909272990000_bib50","doi-asserted-by":"crossref","unstructured":"Vessey\n              M\n            \n            \n              Painter\n              R\n            \n          \n          2006\n          Oral contraceptive use and cancer. Findings in a large cohort study, 1968\u20132004. British Journal of Cancer95385\u2013389doi:10.1038\/sj.bjc.6603260.","DOI":"10.1038\/sj.bjc.6603260"},{"key":"2026070909272990000_bib51","doi-asserted-by":"crossref","unstructured":"Weiderpass\n              E\n            \n            \n              Adami\n              H-O\n            \n            \n              Baron\n              JA\n            \n            \n              Magnusson\n              C\n            \n            \n              Lindgren\n              A\n            \n            \n              Perrson\n              I\n            \n          \n          1999\n          Use of oral contraceptives and endometrial cancer (Sweden). Cancer Causes and Control10277\u2013284doi:10.1023\/A:1008945721786.","DOI":"10.1023\/A:1008945721786"},{"key":"2026070909272990000_bib52","doi-asserted-by":"crossref","unstructured":"Weiss\n              NS\n            \n            \n              Sayvetz\n              TA\n            \n          \n          1980\n          Incidence of endometrial cancer in relation to the use of oral contraceptives. New England Journal of Medicine302551\u2013554doi:10.1056\/NEJM198003063021004.","DOI":"10.1056\/NEJM198003063021004"},{"key":"2026070909272990000_bib53","doi-asserted-by":"crossref","unstructured":"WHO Study of Neoplasia and Sterord Contraceptives\n          Endometrial cancer and combined oral contraceptives\n          International Journal of Epidemiology\n          17\n          1988\n          263\u2013269doi:10.1093\/ije\/17.2.263.","DOI":"10.1093\/ije\/17.2.263"},{"key":"2026070909272990000_bib54","doi-asserted-by":"crossref","unstructured":"WHO Collaborative Study of Neoplasia and Steroid Contraceptives\n          Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma\n          International Journal of Cancer\n          49\n          1991a\n          870\u2013874doi:10.1002\/ijc.2910490612.","DOI":"10.1002\/ijc.2910490612"},{"key":"2026070909272990000_bib55","unstructured":"WHO Collaborative Study of Neoplasia and Steroid Contraceptives\n          Depot-medroxyprogesterone acetate and risk of endometrial cancer\n          International Journal of Cancer\n          49\n          1991b\n          186\u2013190."},{"key":"2026070909272990000_bib56","doi-asserted-by":"crossref","unstructured":"Wildemeersch\n              D\n            \n            \n              Janssens\n              D\n            \n            \n              Pylyser\n              K\n            \n            \n              De Wever\n              N\n            \n            \n              Verbeeck\n              G\n            \n            \n              Dhont\n              M\n            \n            \n              Tjalma\n              W\n            \n          \n          2007\n          Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing system: long-term follow-up. Maturitas57210\u2013213doi:10.1016\/j.maturitas.2006.12.004.","DOI":"10.1016\/j.maturitas.2006.12.004"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/17\/4\/R263.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/17\/4\/R263\/193548\/r263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/17\/4\/R263\/193548\/r263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:27:42Z","timestamp":1783603662000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/17\/4\/R263\/34695\/Hormonal-contraception-and-risk-of-endometrial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,1]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12,1]]}},"URL":"https:\/\/doi.org\/10.1677\/erc-10-0076","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,1]]}}}